Abhishek Kumar Verma and Mayadhar Barik*
Assistant Professor, Department of Biochemistry, School of Sciences and Technology, Mewar University, Chittorgarh, India
*Corresponding Author: Mayadhar Barik, Chief Researcher Basic and Clinical Sciences under Science and Technology Division and Associate Professor in Department of Biochemistry and Head of the Department of Paramedical Sciences at Mewar University, Chittorgarh, India.
Received: July 01, 2020; Published: July 18, 2020
Currently, coronaviruses are contagious pathogens and primarily responsible for respiratory and intestinal infections (RIIs). Research on progress to develop antiviral agents (AVAs) against these coronavirus. Researcher had been demonstrated that the main protease (Mpro) protein may represents an effective drug target (EDT) [1]. The novel Corona-virus (n-CoV), recently called as the severe acute respiratory syndrome coronavirus (SARS-CoV-2). The need of the hour is required progress on research into drugs to treat this infection. SARS-CoV-2 remains essential in several research laboratories among the both (national and international).
Citation: Abhishek Kumar Verma and Mayadhar Barik. “Natural Compounds against the Main Protease (Mpro) SARS-CoV-2 through In Silico Approach". Acta Scientific Pharmaceutical Sciences 4.8 (2020): 40-41.
Copyright: © 2020 Abhishek Kumar Verma and Mayadhar Barik. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
+91 9182824667
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
